Cargando…
A screen for transcription factor targets of Glycogen Synthase Kinase-3 highlights an inverse correlation of NFκB and Androgen Receptor Signaling in Prostate Cancer
Expression of Glycogen Synthase Kinase-3 (GSK-3) is elevated in prostate cancer and its inhibition reduces prostate cancer cell proliferation, in part by reducing androgen receptor (AR) signaling. However, GSK-3 inhibition can also activate signals that promote cell proliferation and survival, which...
Autores principales: | Campa, Victor M., Baltziskueta, Eder, Bengoa-Vergniory, Nora, Gorroño-Etxebarria, Irantzu, Wesołowski, Radosław, Waxman, Jonathan, Kypta, Robert M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226675/ https://www.ncbi.nlm.nih.gov/pubmed/25327559 |
Ejemplares similares
-
Frizzled-8 integrates Wnt-11 and transforming growth factor-β signaling in prostate cancer
por: Murillo-Garzón, Virginia, et al.
Publicado: (2018) -
Wnt-11 as a Potential Prognostic Biomarker and Therapeutic Target in Colorectal Cancer
por: Gorroño-Etxebarria, Irantzu, et al.
Publicado: (2019) -
Protective effect of stromal Dickkopf-3 in prostate cancer: opposing roles for TGFBI and ECM-1
por: Al Shareef, Zainab, et al.
Publicado: (2018) -
Proteomic Studies Reveal Disrupted in Schizophrenia 1 as a Player in Both Neurodevelopment and Synaptic Function
por: Ramos, Adriana, et al.
Publicado: (2018) -
Intravital imaging of Wnt/β-catenin and ATF2-dependent signalling pathways during tumour cell invasion and metastasis
por: Stoletov, Konstantin, et al.
Publicado: (2023)